Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
European Hematology Association (EHA) 2016 Congress
June 09 - 12, 2016; Copenhagen, Denmark
June 09 - 12, 2016Copenhagen, Denmark
EHABlinatumomab Beats Chemo for R/R ALL: Survival DoubledThe single-agent immunotherapy was superior to chemotherapy in relapsed/refractory acute lymphoblastic leukemia, almost doubling overall survival in the phase 3 TOWER trial.
Medscape Medical News, June 16, 2016
EHACAR T Cells Effective in Advanced Lymphoma The CAR T-cell approach shows encouraging rates of complete responders even when preceded with low-dose chemotherapy, and 'troublesome' neurotoxic adverse events typically resolve within days.
Medscape Medical News, June 15, 2016
EHALatest Daratumumab Results Herald 'New Era' in MyelomaAnother daratumumab trial shows benefit in relapsed myeloma, with the highest response rates ever seen; the findings herald a 'new era of immunotherapies,' says expert.
